Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company's flagship product—the Abilitech Assist—is a commercially available powered orthotic device designed to restore functional independence in individuals with upper-limb neuromuscular weakness. It provides mechanical assistance to both the shoulder and elbow joints and has been clinically tested in collaboration with leading rehabilitation centers. The device requires minimal patient strength and supports activities of daily living such as eating and self-care. No drug clinical trials are involved. Clinical relationships include collaborations with University of Minnesota, Gillette Children’s Specialty Healthcare, HealthPartners Neuroscience Center, Courage Kenny Rehabilitation Institute/Allina Health. The company received a Medical Device Establishment License from Health Canada in March 2022. No traditional clinical trial results as for drugs; product efficacy demonstrated through user experience and clinical partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abilitech Medical.